Search

everythinglearnresearchcommunity

for

Search:↓

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Th22 cells are essential for Tβ15-induced hair growth in mice.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

The skin is a complex barrier that protects the body, regulates temperature, and helps with immune responses.

Pimecrolimus cream is not effective for treating alopecia areata.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Dupilumab may cause hair loss, so patients should be monitored.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.